In a surprising development, the FDA has approved a third COVID-19 vaccine, the Novavax COVID-19 vaccine. This decision, made after an initial delay, raises questions about the motivations behind the approval and the potential impact on public health. The vaccine had already been available under an Emergency Use Authorization (EUA) since 2022, during which time numerous adverse events, including deaths, were reported.

The FDA's approval is conditional, limiting its use to older adults and children over 12 with pre-existing health conditions. This selective approach raises concerns about whether the decision is driven by public health considerations or financial motives, particularly given the potential cost savings associated with reducing the burden on Medicare and Medicaid.

Conservatives have promoted the Novavax vaccine as a preferable alternative to mRNA vaccines due to its non-mRNA nature and claims that it did not use fetal tissue in production. However, these claims have been disputed, with reports indicating the use of fetal cell lines in the testing phase. This revelation complicates the narrative of Novavax as a "pro-life vaccine" and raises questions about the integrity of the approval process.

The approval of Novavax also raises concerns about the influence of individuals within the FDA and HHS, particularly in light of past criticisms of the agency's handling of COVID-19 vaccines. The close relationship between HHS leadership and certain senators further fuels suspicions about political interference in the approval process.

Critics argue that the FDA's conditional approval oversteps its authority and deprives individuals of the opportunity to make informed choices about vaccination. They also point to the potential financial incentives driving vaccine production and distribution, suggesting that the focus is on profit rather than public health.

The approval of Novavax highlights the complexities and controversies surrounding COVID-19 vaccines, raising questions about the role of government agencies, pharmaceutical companies, and political actors in shaping public health policy. It underscores the need for transparency, accountability, and critical evaluation of the information presented to the public.

The article further references related topics, including the nature of the times we live in, citizenship, the influence of evil, opposition to the Jewish state, distinguishing true prophets, control of the world, Christian Zionism, Freemasonry, Luciferian globalists, the brain myth, and the true nature of Christianity.